Troponin T in the first 24 hours after the administration of chemotherapy and the detection of myocardial damage in children

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
L C M KremerP A Voûte

Abstract

Early detection of damage to cardiac myocytes after cardiotoxic chemotherapy in paediatric patients may allow timely preventive measures to be taken. We investigated the diagnostic value of cardiac troponin T (cTnT) after the administration of cardiotoxic chemotherapy. In 38 children, cTnT levels were measured at three time points during the first 24 h after 58 cardiotoxic chemotherapy cycles (163 samples). An abnormal cTnT level, defined as a cTnT>0.010 ng/ml, was measured in only six samples from 3 patients. After completion of chemotherapy, 7 out of the 38 patients had left ventricular dysfunction (LV dysfunction). Only 1 of these 7 patients had an elevated cTnT level. 2 other patients with elevated cTnT levels did not develop LV dysfunction until 2 and 7 months after the cTnT measurement. Our data show that the measurement of cTnT within 24 h after administration of chemotherapy does not have a high sensitivity for the identification of patients with subsequent subclinical cardiotoxicity.

References

Feb 1, 1977·The American Journal of Medicine·D D Von HoffF M Muggia
Nov 1, 1996·Archives of Disease in Childhood·F A Bu'LockR P Martin
Feb 27, 1999·The New England Journal of Medicine·S E LipshultzS D Colan
Jul 2, 1999·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·K HallermayerR Vogel
Aug 10, 2000·Journal of the American College of Cardiology·D CardinaleC Fiorentini
Mar 20, 2001·Lancet·H W AunerH Sill

❮ Previous
Next ❯

Citations

Oct 20, 2010·Pediatric Cardiology·Osman OzdemirRana Olgunturk
Jan 15, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Fotiní DodosUta C Hoppe
Mar 11, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E C van DalenL C M Kremer
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rachel KneenNicholas J White
Apr 9, 2010·Anti-cancer Drugs·Sandra GeigerHans-Joachim Stemmler
Jun 5, 2008·Pediatric Blood & Cancer·Ioannis GermanakisMaria Kalmanti
Feb 14, 2006·Seminars in Oncology·Raymond NgMichael D Green
Jun 27, 2012·Pediatric Hematology and Oncology·Maëlle de Ville de GoyetBénédicte Brichard
Jan 31, 2008·Leukemia & Lymphoma·Morie A Gertz
Dec 3, 2014·Clinical Biochemistry·Eric S ChristensonBen H Park
Oct 19, 2006·Expert Opinion on Drug Safety·Robin L JonesMichael S Ewer
Oct 14, 2008·Pediatric Hematology and Oncology·Annelies M C Mavinkurve-GroothuisJacqueline Groot-Loonen
Dec 21, 2007·The Annals of Pharmacotherapy·Abigail JannazzoMark Lutz
Jun 4, 2016·Biomarkers in Cancer·Christine HenriJean-Claude Tardif
Dec 5, 2002·Pharmacoepidemiology and Drug Safety
Jan 12, 2008·Pediatrics·Sadhna M ShankarUNKNOWN Cardiovascular Disease Task Force of the Children's Oncology Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
S KilickapG Tekuzman
Journal of the National Cancer Institute
M RadererJ Kastner
Investigational New Drugs
D A VorobiofA P Terblanche
© 2022 Meta ULC. All rights reserved